MyChart Proxy Outreach to Parents (MyPOP)

Conditions

• Health Technology

Eligibility Criteria

Sex

ALL

Age

18 Years - N/A

Healthy Volunteers

Accepted

Interventions

• Email — BEHAVIORAL
  Email message sent to guardian with proxy information.
• Text — BEHAVIORAL
  Text message sent to guardian with proxy information.
• Patient Portal Message — BEHAVIORAL
  Patient portal message (MyChart) to guardian with proxy information.

Study Details

The goal of this randomized controlled trial is to assess the extent to which different modes of contacting parents who have not yet enabled to access to their children's medical records will result in greater proxy access. The main questions the study aims to answer are: * will outreach via text or patient portal message result in more parents having access than usual care (which is in-office suggestions to get access). * which mode - text or portal - will get more parents access. Participants will get a text message, or a portal message through their own patient portal, or no message. The investigators will check access to see which group has increased more during the study period.

Key Dates

Start date

Oct 15, 2024

Status verified

Feb 2026

Primary completion

Sep 30, 2026

Completion

Sep 30, 2026

Study Design

Enrollment

5,200 participants (estimated)

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

HEALTH_SERVICES_RESEARCH

Arms

• No Intervention: Usual Care
  Care as usual
• Experimental: Preferred Modality
  Text or email message to guardian with proxy information. If the guardian has no personal MyChart access, before sending proxy information to set up access to their child's MyChart, the investigators will message the guardian up to two times with information enabling them to access their personal MyChart.
• Experimental: Patient Portal
  Patient portal message (MyChart) to guardian with proxy information. If the guardian has no personal MyChart access, before sending proxy information to set up access to their child's MyChart, the investigators will message the guardian up to two times with information enabling them to access their personal MyChart.

Primary Outcome Measure

Proportion of participants who activate MyChart Proxy Access [ Time Frame: up to 12 weeks ]

Central Contacts

• Ada Fenick, MD
  203-688-2475
  [email protected]

Locations (4)

Find similar trials in New Haven, CT